Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A noninteracting low-mass black hole-giant star binary system.
Thompson TA, Kochanek CS, Stanek KZ, Badenes C, Post RS, Jayasinghe T, Latham DW, Bieryla A, Esquerdo GA, Berlind P, Calkins ML, Tayar J, Lindegren L, Johnson JA, Holoien TW, Auchettl K, Covey K. Thompson TA, et al. Among authors: tayar j. Science. 2019 Nov 1;366(6465):637-640. doi: 10.1126/science.aau4005. Science. 2019. PMID: 31672898
A close-in giant planet escapes engulfment by its star.
Hon M, Huber D, Rui NZ, Fuller J, Veras D, Kuszlewicz JS, Kochukhov O, Stokholm A, Rørsted JL, Yıldız M, Orhan ZÇ, Örtel S, Jiang C, Hey DR, Isaacson H, Zhang J, Vrard M, Stassun KG, Shappee BJ, Tayar J, Claytor ZR, Beard C, Bedding TR, Brinkman C, Campante TL, Chaplin WJ, Chontos A, Giacalone S, Holcomb R, Howard AW, Lubin J, MacDougall M, Montet BT, Murphy JMA, Ong J, Pidhorodetska D, Polanski AS, Rice M, Stello D, Tyler D, Van Zandt J, Weiss LM. Hon M, et al. Among authors: tayar j. Nature. 2023 Jun;618(7967):917-920. doi: 10.1038/s41586-023-06029-0. Epub 2023 Jun 28. Nature. 2023. PMID: 37380688
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.
Fa'ak F, Buni M, Falohun A, Lu H, Song J, Johnson DH, Zobniw CM, Trinh VA, Awiwi MO, Tahon NH, Elsayes KM, Ludford K, Montazari EJ, Chernis J, Dimitrova M, Sandigursky S, Sparks JA, Abu-Shawer O, Rahma O, Thanarajasingam U, Zeman AM, Talukder R, Singh N, Chung SH, Grivas P, Daher M, Abudayyeh A, Osman I, Weber J, Tayar JH, Suarez-Almazor ME, Abdel-Wahab N, Diab A. Fa'ak F, et al. Among authors: tayar jh. J Immunother Cancer. 2023 Jun;11(6):e006814. doi: 10.1136/jitc-2023-006814. J Immunother Cancer. 2023. PMID: 37328287 Free PMC article.
Durvalumab-associated generalized morphea with overlapping vitiligo.
Martel J, Cho WC, Runge JS, Patel AB, Tayar J, Woodman K, Hume CB, Curry J, Heberton M. Martel J, et al. Among authors: tayar j. JAAD Case Rep. 2022 Oct 13;30:83-86. doi: 10.1016/j.jdcr.2022.10.007. eCollection 2022 Dec. JAAD Case Rep. 2022. PMID: 36407485 Free PMC article. No abstract available.
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma.
DiPeri TP, Demirhan M, Karp DD, Fu S, Hong DS, Subbiah V, Lim J, Ballester LY, Tayar JH, Suarez-Almazor ME, Javle M, Meric-Bernstam F. DiPeri TP, et al. Among authors: tayar jh. J Immunother Precis Oncol. 2022 Feb 4;5(1):26-30. doi: 10.36401/JIPO-21-18. eCollection 2022 Feb. J Immunother Precis Oncol. 2022. PMID: 35663835 Free PMC article.
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
Kim ST, Chu Y, Misoi M, Suarez-Almazor ME, Tayar JH, Lu H, Buni M, Kramer J, Rodriguez E, Hussain Z, Neelapu SS, Wang J, Shah AY, Tannir NM, Campbell MT, Gibbons DL, Cascone T, Lu C, Blumenschein GR, Altan M, Lim B, Valero V, Loghin ME, Tu J, Westin SN, Naing A, Garcia-Manero G, Abdel-Wahab N, Tawbi HA, Hwu P, Oliva ICG, Davies MA, Patel SP, Zou J, Futreal A, Diab A, Wang L, Nurieva R. Kim ST, et al. Among authors: tayar jh. Nat Commun. 2022 Apr 12;13(1):1970. doi: 10.1038/s41467-022-29539-3. Nat Commun. 2022. PMID: 35413951 Free PMC article.
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center.
Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Robinson JD, et al. Among authors: tayar j. Am J Addict. 2022 May;31(3):236-241. doi: 10.1111/ajad.13282. Epub 2022 Mar 28. Am J Addict. 2022. PMID: 35347796 Free PMC article. Clinical Trial.
30 results